APA (7th ed.) Citation

E. S. Kropacheva, E. N. Krivosheeva, & E. P. Panchenko. (2021). Rivaroxaban in patients with atrial fibrillation: From research to real practice (based on REGistry of Long-term AnTithrombotic TherApy-2 (REGATA)). «REMEDIUM GROUP» Ltd..

Chicago Style (17th ed.) Citation

E. S. Kropacheva, E. N. Krivosheeva, and E. P. Panchenko. Rivaroxaban in Patients with Atrial Fibrillation: From Research to Real Practice (based on REGistry of Long-term AnTithrombotic TherApy-2 (REGATA)). «REMEDIUM GROUP» Ltd., 2021.

MLA (9th ed.) Citation

E. S. Kropacheva, et al. Rivaroxaban in Patients with Atrial Fibrillation: From Research to Real Practice (based on REGistry of Long-term AnTithrombotic TherApy-2 (REGATA)). «REMEDIUM GROUP» Ltd., 2021.